Evidence map›Paper›PMID 39604421›Full record

ArticleScientific reports2024

Hybrid sequencing for detailed genetic characterization of human adenoviruses.

Bin Fang, Juan Lai, Yongfeng Liu, Lin-Lin Liu, Xiao Yu, Xiang Li, Haili Ke, Xianfeng Zhang, Xin Zhang

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bin Fang *Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.
Juan Lai *GeneMind Biosciences Company Limited, Shenzhen, 518001, China.
Yongfeng Liu *GeneMind Biosciences Company Limited, Shenzhen, 518001, China.
Lin-Lin LiuHubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.
Xiao YuHubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.
Xiang LiHubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.
Haili KeGeneMind Biosciences Company Limited, Shenzhen, 518001, China.
Xianfeng ZhangHubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China. hbcdczhangxf@163.com.
Xin ZhangGeneMind Biosciences Company Limited, Shenzhen, 518001, China. 603986119@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human adenoviruses (HAdVs) are highly contagious and have significant clinical implications in the pediatric population. In the present study, we employed a combination of long-read sequencing and short-read sequencing to accurately reconstruct 32 genomes of HAdVs. The phylogenetic analyses based on the whole genome and genes revealed distinct sub-clusters within HAdV-B and -E. For HAdV-C, the phylogenetic trees constructed from hexon, fiber, and E3 gene sequences consistently matched the whole-genome phylogeny, reflecting the high sequence diversity in these regions. Notably, in regions with high sequence diversity, we observed a higher number of recombination breakpoints and lower GC content. Additionally, the E4 gene region of HAdV-C exhibited a Ka/Ks ratio > 1, indicating that positive selection may be driving the fixation of advantageous mutations. These genetic characterization analyses are crucial for enhancing future surveillance of HAdVs, facilitating a more strategic and proactive approach to monitoring their evolution, diversity, and epidemiological trends.

Indexed as

Adenoviruses, HumanGenome, ViralPhylogenyAdenovirus Infections, HumanGenetic VariationHumansSequence Analysis, DNACo-infectionEvolutionFASTASeq 300HAdVONTRecombination

Identifiers

PMID39604421
PMCPMC11603307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.